Related Experiment Video
Updated: May 19, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Placental prostate-specific antigen content in preeclampsia
Murat Can1, Serefden Acikgoz, Berrak Guven
1Department of Biochemistry, Faculty of Medicine, Karaelmas University, Zonguldak, Turkey. drcanmurat@yahoo.com
Acta Biochimica Polonica
|August 3, 2012
Summary
Preeclampsia is linked to higher placental prostate-specific antigen (PSA) levels, especially in cases with intrauterine growth restriction (IUGR). Elevated placental PSA also correlates with lower infant birth weight in preeclamptic pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Biology
- Pathophysiology
Background:
- Preeclampsia is a serious pregnancy complication characterized by hypertension and proteinuria.
- Placental prostate-specific antigen (PSA) presence is known in normal pregnancies, but its role in preeclampsia remains uninvestigated.
Purpose of the Study:
- To investigate the content of PSA in placentas from women with preeclampsia.
- To explore the relationship between placental PSA levels and intrauterine growth restriction (IUGR) in preeclampsia.
Main Methods:
- Placentas were collected from 33 preeclamptic and 34 normotensive women.
- Tissue PSA content was quantified using the Immulite 2000 PSA assay.
- Statistical analysis included Student's t-test and Pearson correlation.
Main Results:
- Placental PSA content was significantly higher in women with preeclampsia compared to normotensive controls.
- Elevated placental PSA levels were observed in preeclamptic women with IUGR compared to those without IUGR and normotensive controls.
- Placental PSA content showed a negative correlation with infant birth weight.
Conclusions:
- Placental PSA content is elevated in preeclampsia, particularly in cases complicated by IUGR.
- Increased placental PSA is associated with reduced infant birth weight.
- Further research is needed to elucidate the precise role and impact of PSA in preeclampsia pathophysiology.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Gonadal and Placental Hormones
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...